Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition

Abstract Injuries to skeletal muscle are among the most common injuries in civilian and military populations, accounting for nearly 60% of extremity injuries. The standard of care for severe extremity injury has been focused upon limb salvage procedures and the utilization of tissue grafts or orthot...

Full description

Bibliographic Details
Main Authors: J. G. Bartolacci, M. N. Behun, J. P. Warunek, T. Li, A. Sahu, G. K. Dwyer, A. Lucas, J. Rong, F. Ambrosio, H. R. Turnquist, S. F. Badylak
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:npj Regenerative Medicine
Online Access:https://doi.org/10.1038/s41536-024-00346-2
_version_ 1827329370216202240
author J. G. Bartolacci
M. N. Behun
J. P. Warunek
T. Li
A. Sahu
G. K. Dwyer
A. Lucas
J. Rong
F. Ambrosio
H. R. Turnquist
S. F. Badylak
author_facet J. G. Bartolacci
M. N. Behun
J. P. Warunek
T. Li
A. Sahu
G. K. Dwyer
A. Lucas
J. Rong
F. Ambrosio
H. R. Turnquist
S. F. Badylak
author_sort J. G. Bartolacci
collection DOAJ
description Abstract Injuries to skeletal muscle are among the most common injuries in civilian and military populations, accounting for nearly 60% of extremity injuries. The standard of care for severe extremity injury has been focused upon limb salvage procedures and the utilization of tissue grafts or orthotics in conjunction with rehabilitation to avoid amputation. Nonetheless, many patients have persistent strength and functional deficits that permanently impact their quality of life. Preclinical and clinical studies have shown that partial restoration of functional skeletal muscle tissue following injury can be achieved by the implantation of a biologic scaffold composed of extracellular matrix (ECM). These favorable outcomes are mediated, at least in part, through local immunomodulation. The mechanisms underlying this immunomodulatory effect, however, are poorly understood. The present study investigates a potential mechanistic driver of the immunomodulatory effects; specifically, the effect of selected ECM components upon inflammation resolution and repair. Results show that the host response to skeletal muscle injury is profoundly altered and functional recovery decreased in il33 −/− mice compared to age- and sex-matched wildtype counterparts by 14 days post-injury. Results also show that IL-33, contained within matrix-bound nanovesicles (MBV), supports skeletal muscle regeneration by regulating local macrophage activation toward a pro-remodeling phenotype via canonical and non-canonical pathways to improve functional recovery from injury compared to untreated il33 −/− counterparts. Taken together, these data suggest that MBV and their associated IL-33 cargo represent a novel homeostatic signaling mechanism that contributes to skeletal muscle repair.
first_indexed 2024-03-07T15:32:08Z
format Article
id doaj.art-dd0c23d5c408456b8f09870666fecc78
institution Directory Open Access Journal
issn 2057-3995
language English
last_indexed 2024-03-07T15:32:08Z
publishDate 2024-01-01
publisher Nature Portfolio
record_format Article
series npj Regenerative Medicine
spelling doaj.art-dd0c23d5c408456b8f09870666fecc782024-03-05T16:22:18ZengNature Portfolionpj Regenerative Medicine2057-39952024-01-019111110.1038/s41536-024-00346-2Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transitionJ. G. Bartolacci0M. N. Behun1J. P. Warunek2T. Li3A. Sahu4G. K. Dwyer5A. Lucas6J. Rong7F. Ambrosio8H. R. Turnquist9S. F. Badylak10Department of Bioengineering, University of PittsburghDepartment of Bioengineering, University of PittsburghDepartments of Surgery and Immunology, University of Pittsburgh Medical CenterDepartments of Surgery and Immunology, University of Pittsburgh Medical CenterDepartment of Physical Medicine and Rehabilitation Sciences, University of PittsburghDepartments of Surgery and Immunology, University of Pittsburgh Medical CenterDepartments of Surgery and Immunology, University of Pittsburgh Medical CenterMcGowan Institute for Regenerative MedicineDepartment of Bioengineering, University of PittsburghDepartments of Surgery and Immunology, University of Pittsburgh Medical CenterDepartment of Bioengineering, University of PittsburghAbstract Injuries to skeletal muscle are among the most common injuries in civilian and military populations, accounting for nearly 60% of extremity injuries. The standard of care for severe extremity injury has been focused upon limb salvage procedures and the utilization of tissue grafts or orthotics in conjunction with rehabilitation to avoid amputation. Nonetheless, many patients have persistent strength and functional deficits that permanently impact their quality of life. Preclinical and clinical studies have shown that partial restoration of functional skeletal muscle tissue following injury can be achieved by the implantation of a biologic scaffold composed of extracellular matrix (ECM). These favorable outcomes are mediated, at least in part, through local immunomodulation. The mechanisms underlying this immunomodulatory effect, however, are poorly understood. The present study investigates a potential mechanistic driver of the immunomodulatory effects; specifically, the effect of selected ECM components upon inflammation resolution and repair. Results show that the host response to skeletal muscle injury is profoundly altered and functional recovery decreased in il33 −/− mice compared to age- and sex-matched wildtype counterparts by 14 days post-injury. Results also show that IL-33, contained within matrix-bound nanovesicles (MBV), supports skeletal muscle regeneration by regulating local macrophage activation toward a pro-remodeling phenotype via canonical and non-canonical pathways to improve functional recovery from injury compared to untreated il33 −/− counterparts. Taken together, these data suggest that MBV and their associated IL-33 cargo represent a novel homeostatic signaling mechanism that contributes to skeletal muscle repair.https://doi.org/10.1038/s41536-024-00346-2
spellingShingle J. G. Bartolacci
M. N. Behun
J. P. Warunek
T. Li
A. Sahu
G. K. Dwyer
A. Lucas
J. Rong
F. Ambrosio
H. R. Turnquist
S. F. Badylak
Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition
npj Regenerative Medicine
title Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition
title_full Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition
title_fullStr Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition
title_full_unstemmed Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition
title_short Matrix-bound nanovesicle-associated IL-33 supports functional recovery after skeletal muscle injury by initiating a pro-regenerative macrophage phenotypic transition
title_sort matrix bound nanovesicle associated il 33 supports functional recovery after skeletal muscle injury by initiating a pro regenerative macrophage phenotypic transition
url https://doi.org/10.1038/s41536-024-00346-2
work_keys_str_mv AT jgbartolacci matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT mnbehun matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT jpwarunek matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT tli matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT asahu matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT gkdwyer matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT alucas matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT jrong matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT fambrosio matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT hrturnquist matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition
AT sfbadylak matrixboundnanovesicleassociatedil33supportsfunctionalrecoveryafterskeletalmuscleinjurybyinitiatingaproregenerativemacrophagephenotypictransition